Delivery Order SPE2DR25D3006-SPE2DR26FR0BD
- Not listed
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp on September 18, 2025, for the supply of Atomoxetine HCL 18 mg capsules (30-count units) with a ceiling value of $1,535.40. This is a firm fixed-price delivery order with an ultimate completion date of September 19, 2025, and was awarded without set-aside restrictions through competitive procurement. The work will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 5, 2025, for the supply of Atomoxetine HCL 25 mg capsules in quantities of 30 units, with a contract ceiling value of $2,326.72. This is a firm fixed price delivery order with an ultimate completion date of September 8, 2025, and was awarded on a non-set-aside, competitive basis. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Atomoxetine HCL 60 mg capsules (30-count units) with a ceiling value of $1,096.92. This competitively awarded, firm fixed-price delivery order is non-set-aside and is scheduled for completion by September 9, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Atomoxetine HCL 18 mg capsules (30-count) on August 12, 2025, with a ceiling value of $1,569.60 and ultimate completion date of August 13, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and represents a pharmaceutical supply delivery executed through AmerisourceBergen's existing contract vehicle with DLA. The place of performance is the vendor's corporate office...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Atomoxetine HCL 40 mg capsules (30-count units) under a firm fixed-price contract. The award, issued on November 26, 2025, carries a ceiling value of $4,699.10 and requires completion by November 28, 2025. The contract is non-competitive and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 22, 2025, for the supply of Atomoxetine HCL 18 mg capsules (30-count units) with a contract value of $1,935.72. This non-set-aside, competitively awarded delivery order represents a firm fixed-price transaction with an ultimate completion date of August 25, 2025. The award is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 5, 2025, for the supply of Atomoxetine HCL 60 mg capsules (30-count units) with a ceiling value of $1,012.36. This competitively awarded, firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The contract carries no set-aside...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Atomoxetine HCL 18 mg capsules (30-count) with a ceiling value of $1,128.46. This competitively awarded, firm fixed-price delivery order was issued on December 2, 2025, with an ultimate completion date of December 3, 2025. The contract requires performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, and represents a small-value pharmaceutical supply...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency valued at $1,453.90 for the supply of Atomoxetine HCL 10 mg capsules (30-count units). This award, issued on July 31, 2025, represents a firm fixed-price delivery order with an ultimate completion date of August 1, 2025, to be performed at the company's corporate headquarters in Conshohocken, Pennsylvania. The contract was competitively awarded with no set-aside designation. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order valued at $1,463.14 to AmerisourceBergen Drug Corp for the supply of Atomoxetine HCL 18 mg capsules (30-count) with an ultimate completion date of May 7, 2025. This non-set-aside contract employs firm fixed-price terms and represents a competitive award to support federal pharmaceutical procurement needs. The contract will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This delivery order is issued...
- SPE2DR25D3006Indefinite Delivery Contract
- SPE2DR25D3006-SPE2DR26FR0BDDelivery Order
The Defense Logistics Agency awarded a firm fixed-price delivery order to AmerisourceBergen Drug Corp on December 8, 2025, for the supply of Atomoxetine HCL 25 mg capsules in 30-count quantities, with a contract ceiling value of $2,955.73 and an ultimate completion date of December 9, 2025. This non-set-aside delivery order represents a competitively awarded purchase executed under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement supporting military and veteran healthcare systems. The company maintains an extensive portfolio of pharmaceutical deliveries to the DLA and Defense Health Agency, encompassing a wide range of therapeutic medications including neurological treatments, pain management pharmaceuticals, and specialty medications. This delivery order reflects AmerisourceBergen's ongoing role as a primary supplier within the DLA's Medical Supply Chain, fulfilling the pharmaceutical needs of the Department of Defense and related federal healthcare programs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.0k | 12/7/25 |